Skinvisible EBIT

The latest EBIT for SKVI is $-460K as of June 2026. That compares with $93K in the prior-year period — down 593.4% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Skinvisible's historical trend and sector peers before judging valuation or financial health.

Over the past year, SKVI's EBIT moved from $93K to $-460K — a 593.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Skinvisible's operating scale or balance-sheet position.

Against its sector companies, SKVI currently prints $-460K for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Skinvisible's growth, margins, and balance sheet.

A EBIT figure of $-460K for SKVI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting SKVI's EBIT ($-460K), review year-over-year change from $93K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.